Price Alert

Amedisys Inc. (AMED)

NASDAQ: AMED · Real-Time Price · USD

100.99

0.01 (0.01%)

At close: Aug 14, 2025, 3:59 PM

101.00

0.01%

After-hours: Aug 14, 2025, 07:38 PM EDT

Amedisys Statistics

Share Statistics

Amedisys has 32.89M shares outstanding. The number of shares has increased by 0.24% in one year.

Shares Outstanding	32.89M
Shares Change (YoY)	0.24%
Shares Change (QoQ)	0.03%
Owned by Institutions (%)	87.87%
Shares Floating	32.12M
Failed to Deliver (FTD) Shares	46
FTD / Avg. Volume	0.01%

Short Selling Information

The latest short interest is 2.24M, so 6.83% of the outstanding shares have been sold short.

Short Interest	2.24M
Short % of Shares Out	6.83%
Short % of Float	6.95%
Short Ratio (days to cover)	4.3

Valuation Ratios

The PE ratio is 68.71 and the forward PE ratio is 19.6. Amedisys's PEG ratio is -0.13.

PE Ratio	68.71
Forward PE	19.6
PS Ratio	1.26
Forward PS	1.3
PB Ratio	2.62
P/FCF Ratio	13.81
PEG Ratio	-0.13

Financial Ratio History

Enterprise Valuation

Amedisys has an Enterprise Value (EV) of 3.13B.

EV / Sales	1.33
EV / EBITDA	42.58
EV / EBIT	14.11
EV / FCF	14.54

Financial Position

The company has a current ratio of 1.23, with a Debt / Equity ratio of 0.41.

Current Ratio	1.23
Quick Ratio	1.23
Debt / Equity	0.41
Debt / EBITDA	6.27
Debt / FCF	2.14
Interest Coverage	3.07

Financial Efficiency

Return on Equity is 3.81% and Return on Invested Capital is 2.48%.

Return on Equity	3.81%
Return on Assets	2.02%
Return on Invested Capital	2.48%
Revenue Per Employee	$123.6K
Profits Per Employee	$2.28K
Employee Count	19,000
Asset Turnover	1.1
Inventory Turnover	n/a

Taxes

Income Tax	48.05M
Effective Tax Rate	55.74%

Stock Price Statistics

The stock price has increased by 3.02% in the last 52 weeks. The beta is 0.9, so Amedisys's price volatility has been higher than the market average.

Beta	0.9
52-Week Price Change	3.02%
50-Day Moving Average	97.22
200-Day Moving Average	93.33
Relative Strength Index (RSI)	74.49
Average Volume (20 Days)	481,854

Income Statement

In the last 12 months, Amedisys had revenue of 2.35B and earned 43.23M in profits. Earnings per share was 1.32.

Revenue	2.35B
Gross Profit	1.02B
Operating Income	94.54M
Net Income	43.23M
EBITDA	73.45M
EBIT	55.45M
Earnings Per Share (EPS)	1.32

Full Income Statement

Balance Sheet

The company has 303.24M in cash and 460.18M in debt, giving a net cash position of -156.94M.

Cash & Cash Equivalents	303.24M
Total Debt	460.18M
Net Cash	-156.94M
Retained Earnings	791.16M
Total Assets	2.22B
Working Capital	173.84M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 221.66M and capital expenditures -6.55M, giving a free cash flow of 215.12M.

Operating Cash Flow	221.66M
Capital Expenditures	-6.55M
Free Cash Flow	215.12M
FCF Per Share	6.57

Full Cash Flow Statement

Margins

Gross margin is 43.34%, with operating and profit margins of 4.03% and 1.84%.

Gross Margin	43.34%
Operating Margin	4.03%
Pretax Margin	3.67%
Profit Margin	1.84%
EBITDA Margin	3.13%
EBIT Margin	4.03%
FCF Margin	9.16%

Dividends & Yields

AMED does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	1.46%
FCF Yield	7.24%

Dividend Details

Analyst Forecast

The average price target for AMED is $100.5, which is -0.5% lower than the current price. The consensus rating is "Hold".

Price Target	$100.5
Price Target Difference	-0.5%
Analyst Consensus	Hold
Analyst Count	2

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	$6.6
Lynch Upside	-93.46%
Graham Number	32.11
Graham Upside	-68.2%

Stock Splits

The last stock split was on Dec 5, 2006. It was a forward split with a ratio of 4:3.

Last Split Date	Dec 5, 2006
Split Type	forward
Split Ratio	4:3

Scores

Altman Z-Score	4.05
Piotroski F-Score	7